Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | FNTA | P49354 | 6/20 | 0.44 |
| ▸ | FNTB | P49356 | 6/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7681530 | 0.93 | FNTA (0.43) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7681980 | 0.92 | FNTA (0.48) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7687366 | 0.90 | FNTA (0.45) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7690190 | 0.89 | FNTA (0.48) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7689564 | 0.89 | FNTA (0.44) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7683704 | 0.88 | FNTA (0.44) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7681543 | 0.87 | FNTA (0.47) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7626193 | 0.86 | FNTA (0.47) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7687530 | 0.84 | FNTA (0.44) | ALDH1A1KDM4EFNTAFNTBPGGT1B | |
| SCHEMBL7683740 | 0.84 | FNTA (0.44) | ALDH1A1KDM4EFNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020052363-A1 | Inhibitors of prenyl-protein transferase | DINSMORE CHRISTOPHER J (US) | 2002-05-02 | — | — | US | claimed |
| US-20020052363-A1 | Inhibitors of prenyl-protein transferase | DINSMORE CHRISTOPHER J (US) | 2002-05-02 | — | — | US | disclosed |
| WO-2001060369-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052363-A1 | Inhibitors of prenyl-protein transferase | FNTA, FNTB, PTAR1 | ALDH1A1 1461/4885KDM4E 2677/4885FNTA 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.